Comment on "Durability of response to primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel: OLYMPUS trial final report".
World J Urol
; 40(5): 1251-1252, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-35191990
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
Carcinoma, Transitional Cell
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
World J Urol
Year:
2022
Type:
Article
Affiliation country:
China